Related Experiment Video
Updated: Jul 2, 2025

07:50
Establishment of a Clinic-based Biorepository
Published on: May 29, 2017
6.5K
An unusual case of pilonidal p16 positive squamous cell carcinoma-a case report
Hershil Khatri1, Tzu-Yi Chuang1, Daniel Swan1
1Department of General Surgery, Ipswich Hospital, Ipswich, QLD 4305, Australia.
Journal of Surgical Case Reports
|February 23, 2024
Summary
This is the first reported case of primary cutaneous basaloid squamous cell carcinoma (BSCC) in an elderly woman, linked to chronic psoriasis. Radiotherapy proved effective for this rare and aggressive cancer.
Area of Science:
- Oncology
- Dermatology
- Virology
Background:
- Basaloid squamous cell carcinoma (BSCC) is a rare, aggressive cancer subtype.
- It is frequently associated with p16-expression and high-risk human papillomavirus (HPV), particularly in oropharyngeal and anogenital sites.
- P16-expression serves as a surrogate marker for oncogenic HPV16.
Observation:
- A case of primary cutaneous p16-positive BSCC is presented in an elderly woman.
- The patient had a history of chronic inverse psoriasis in the natal cleft.
- This represents a rare instance of malignant transformation in pilonidal disease, especially in an elderly demographic.
Findings:
- This case is the first documentation of primary cutaneous p16-positive BSCC.
- The patient's extensive cutaneous disease and p16-positivity led to treatment with radiotherapy.
- Radiotherapy was an effective primary treatment modality for this patient's condition.
Implications:
- Highlights the importance of considering p16-expression testing in primary cutaneous BSCC, similar to its use in other sites.
- Suggests radiotherapy as a viable treatment option for extensive or p16-positive primary cutaneous BSCC.
- Expands understanding of BSCC's occurrence in atypical demographics and its association with chronic inflammatory skin conditions.

